22nd Century Group, the biotech company that entered the cannabis space in 2014 with ambitions to monetize cannabis genetics, is abandoning the effort. In 2018, they doubled down on the emerging hemp sector, seeing opportunity in bioinformatics and gene editing. The company is now shedding its cannabis operations, GVB Pharma, selling to Nevada-based Specialty Acquisition Corporation for $2.25 million.
…
11.22.2024
Biodiesel margins rise, but window of opportunity limited
Biodiesel margins continued to rise during the week to Friday November 22. The bean oil/heating oil (BOHO) spread boosted margins by falling to its lowest level since August 27.
11.22.2024
Gulf prices average higher despite weeklong declines in SBO
For the week ended Friday November 22, packer bleachable fancy tallow (BFT) remained unchanged from the previous week’s average, while Gulf Coast-delivered tallow rose 2.7%, primarily...
11.22.2024
Bloodmeal largest price mover week on week; November cattle on feed higher
US animal protein prices were mixed to mostly higher for the week to Friday November 22, with only meat and bonemeal showing a slight price reduction due to tighter...